DISEASES OF AQUATIC ORGANISMS
Dis Aquat Org

Vol. 76: 1–6, 2007

Published June 7

Detection of Panulirus argus Virus 1 in Caribbean
spiny lobsters
Megan M. Montgomery-Fullerton1, Roland A. Cooper1, Kathryn M. Kauffman1,
Jeffrey D. Shields2, Robert E. Ratzlaff1,*
2

1
Department of Biological Sciences, MGB 110, Old Dominion University, Norfolk, Virginia 23529-0266, USA
Virginia Institute of Marine Science, The College of William and Mary, Gloucester Point, Virginia 23062, USA

ABSTRACT: Panulirus argus Virus 1 (PaV1) is a pathogenic virus that infects Caribbean spiny
lobsters P. argus in the Florida Keys. We have developed a PCR detection assay for PaV1 for the
purpose of studying the natural history of the virus and for monitoring the prevalence of infection.
The detection of the virus in hemolymph and other tissues is based on the PCR amplification of a
499 bp product using specific primers designed from a cloned fragment of the PaV1 genome. The
sensitivity limit for the assay was 1.2 fg of purified viral DNA. The PaV1 primers did not react with
lobster DNA, oyster DNA, Ostreid Herpesvirus 1, or murine cytomegalovirus. Using this assay, we
successfully followed the course of infection in lobsters inoculated with PaV1 and we detected
infections in wild-caught lobsters from the Florida Keys. We have also established guidelines for
interpreting infection results from the PCR assay for PaV1.
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In 1999, a pathogenic and lethal virus was discovered in juvenile Caribbean spiny lobsters Panulirus argus in the Florida Keys, Florida, USA (Shields
& Behringer 2004). The virus, P. argus Virus 1 (PaV1),
infects hyalinocytes and semigranulocytes in hemolymph, as well as the spongy connective tissues of the
hepatopancreas and other tissues. The ensuing disease develops in 1 to 3 mo and is characterized by the
loss of hemocytes and clotting activity with the
appearance of viral particles in the hemolymph. There
is also a visible change in the hemolymph from clear
or bluish to a white milky color, which is diagnostic
for infection. In addition to changes in hemolymph
characteristics, the reserve inclusion cells in the hepatopancreas are depleted of glycogen, and the hepatopancreas exhibits focal necrosis, ischemia, and
atrophy, which leads to metabolic wasting and lethargy in heavily infected lobsters (Shields & Behringer 2004).

PaV1 has the characteristics of a DNA virus and shares
some morphological characteristics of both the Herpesviridae and the Iridoviridae (Shields & Behringer 2004).
Infected cells have enlarged and irregularly shaped
nuclei, with densely packed, emarginated chromatin.
Virions develop in the nucleus and are icosahedral with
toroid bodies, ~182 nm in diameter.
Initial diagnosis of the disease has been based on
changes in host behavior and appearance, including
the development of cloudy hemolymph, yellowing of
background carapace color, fouling of the carapace,
lethargy, and an increase in solitary occupancy of dens
(Behringer et al. 2006). Confirmation of viral infection
has been based on histopathological disease manifestations and the presence of viral DNA in tissues by a
FISH (fluorescence in situ hybridization) assay (Li et
al. 2007) and by culture-based methods (Li & Shields
2007). Here, we report a specific and sensitive PCR
(polymerase chain reaction) assay that can detect PaV1
in the early stages of infection using a small hemolymph sample from live Panulirus argus.
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MATERIALS AND METHODS
Lobsters. Juvenile spiny lobsters Panulirus argus
were collected in the Florida Keys from shallow (1 to
2 m) sub-tidal habitats, by hand using SCUBA, and
transported in seawater-filled coolers to the Keys
Marine Laboratory, Long Key, Florida, USA. Lobsters
were shipped overnight to the Virginia Institute of
Marine Science, Virginia, USA, where they were
held in 78 l aquaria equipped with aerators and 2
Whisper filters containing preconditioned crushed
coral. Artificial seawater (Marinemix Forty Fathoms,
Marine Enterprises International) in the aquaria
was monitored weekly for pH (7.1 to 7.6), salinity
(33 to 35 ppt), temperature (21 to 24°C), ammonia
(<1.0 ppm), and nitrite (<1.0 ppm), and 50% water
changes were performed to maintain water quality
within acceptable limits. Lobsters were fed squid 3
times per week, and any food remaining in aquaria
after 3 h was removed. Healthy individuals have been
maintained in this system for > 2 yr. Diseased and
healthy animals, distinguished by the presence of discolored hemolymph and obvious signs of morbidity,
were housed in separate aquaria in different rooms.
The virus has been maintained for > 3 yr in the laboratory through repeated passages of infected hemolymph into healthy animals.
All hemolymph samples from healthy, naturally infected, and inoculated lobsters were collected in an
equal volume of citrate anticoagulant (Söderhäll &
Smith 1983) and frozen at –80°C until tested. The stock
anticoagulant solution also contained 20% dimethyl sulfoxide (Sigma-Aldrich), 0.8% protease inhibitor cocktail (Sigma-Aldrich P8340), and 10 IU bacitracin ml–1
(Fisher Scientific). For inoculation trials, pre-inoculation
hemolymph was collected from each lobster immediately prior to needle inoculation with 0.1 ml of pooled,
infected hemolymph from 3 diseased lobsters mixed

1:1 in anticoagulant. In preliminary tests, the injection
of our stock anticoagulant solution alone did not visibly
harm lobsters. Post-inoculation hemolymph was collected and frozen starting on Day 10 and at various
intervals over the subsequent 2 mo.
DNA extraction. Genomic DNA was extracted from
samples for PCR from ~40 µl of hemolymph (diluted
1:1) and ~25 mg of tissue using a QIAamp DNA Mini
Extraction kit (Qiagen) according to the manufacturer’s protocol. Anticoagulant and double-distilled
water (ddH2O) served as negative controls for the DNA
extraction procedure. A pCR4TOPO plasmid (Invitrogen) containing an 892 bp sequence (p892) cloned
from purified PaV1 served as a positive control specific
for the PaV1 primers (GenBank Accession Number
EF206313). Extracted DNA levels from hemolymph
were 5 ± 3 µg ml–1 as determined by fluorometric assay
using Sybr Green II (Corbett et al. 2004, Smilkstein et
al. 2004) with salmon sperm DNA as the standard.
Primers. Using the p892 sequence, specific primers
for PaV1 were designed using the DNA calculator
(www.sigma-genosys.com/calc/DNACalc.asp) and the
SDSC Biology workbench (http://workbench.sdsc.
edu/). The following criteria were applied to design
new primers: GC content from 45 to 60%, minimal secondary structure, no primer dimers, Tm between 50
and 70°C, and length of 20 to 24 bases. The various
primers in the present study were used to detect PaV1,
OsHV1 (Ostreid Herpesvirus 1), and herpes viruses in
general, as well as the plasmid pCR4TOPO (Table 1).
PCR assay. The reagents in each reaction tube used
for the PCR assay for PaV1 were based on an Invitrogen
PCR kit: 1× buffer, 1.5 mM MgCl2, 0.2 mM dNTPs,
0.5 µM for each primer, 1 U of Taq DNA polymerase,
and 5 µl of template containing ~25 ng of DNA in a total
volume of 50 µl. The reactions were run on an MJ Research thermal cycler (Bio-Rad Laboratories). The amplification conditions were 94°C for 10 min, followed by

Table 1. Primers used in the present study. PaVI: Panulirus argus Virus 1; OsHVI: Ostreid Herpesvirus 1; r1 and r2: Round 1
and 2, respectively
ID

Primer sequence (5’ → 3’)
Specificity

PCR
Product size (bp)

Source

45aF
543aR

TTCCAGCCCAGGTACGTATC
AACAGATTTTCCAGCAGCGT

PaV1, r1 and r2

499

Present study

OsC5F
OsC13R
OsC2F
OsC4R

CCG TGACTTCTATGGGTATGTCAG
CCTCGAGGTAGCTTTTGTCAA
CTCTTTACCATGAAGATACCCACC
GCAGTTGTGGTATACTCGAGATTG

OsHV1, r1

765

Batista et al. (2005)

OsHV1, r2

352

DFA
KG1

GAYTTYGCNAGYYTNTAYCC
GTCTTGCTCACCAGNTCNACNCCYTT

Herpes viruses, r1

~745

M13F
M13R

GTAAAACGACGGCCAG
CAGGAAACAGCTATGAC

p305 (pCR4TOPO)

481

Elhers et al. (1999)
Invitrogen K4575-J10
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30 cycles of 94°C for 30 s, 51°C for 30 s, and 72°C for
1 min, with a final extension of 72°C for 10 min. After
several preliminary tests of a single-round PCR with
≥ 30 cycles, we found that the resolution of the 499 bp
PaV1 band compared to the background improved
when a 2-round PCR was employed. Thus, 5 µl of the
first 30 cycle round PCR reaction product was used as
the template in the second round of PCR under the
same conditions, resulting in a 499 bp amplicon in both
rounds. All PCR results shown are Round 2 reactions
unless otherwise noted. The PCR for OsHV1 (Batista et
al. 2005) and a PCR that broadly detects herpes viruses
based on their DNA polymerase genes (Elhers et al.
1999) were run according to published methods.
To establish that extracted hemolymph samples
did not contain PCR reaction inhibitors as a potential
source of false-negative readings, we spiked 5 µl of the
hemolymph DNA extract with 50 ng of a pCR4TOPO
plasmid (Invitrogen) containing a 305 bp insert unrelated to PaV1 (p305). The PaV1 primers were replaced
with plasmid-specific M13 primers that yielded a
481 bp amplicon. The annealing temperature was
adjusted to 49°C for 30 cycles with all other conditions
similar to the PCR assay for PaV1. All PCR products
were electrophoresed in 1.5% agarose for ~45 min at
a constant 6 V cm–1. Each lane was loaded with 0.5 µl
mm–2 of the nominal area at the bottom of a well to
standardize loading volumes among the various sized
gel combs used in the present study.
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Fig. 1. Titration of purified PaV1 DNA shows that the PCR
assay for PaV1 was highly sensitive. Lanes: 1, 100 bp ladder;
2, plasmid p892 positive control; 3, ddH2O control; 4 to 10,
purified PaV1 DNA starting in Round 1 at 120 pg and serially
diluted 10-fold. C: 500 bp marker

RESULTS
The PCR assay for PaV1 was highly sensitive for the
virus using the 45aF and 543aR primer set (Fig. 1). The
DNA from purified PaV1 was titrated in a 2-round
PCR, where Lane 9 showed the 499 bp band at the
lower detection limit of 1.2 fg. Comparing the 2 rounds,
the intensities of the 499 bp band increased in Round 2
at each concentration of PaV1 DNA and the sensitivity
improved 100-fold.
The quantity of lobster genomic DNA necessary to
detect PaV1 in hemolymph was estimated for the PCR
assay by titration using DNA from an inoculated lobster Panulirus argus (Fig. 2). We selected a minimally
infected juvenile lobster that appeared healthy, although it was not possible to determine its actual viral
load. Strong bands were generated at 499 bp, from 12
to 0.012 ng of genomic DNA (Lanes 4 to 7). In all subsequent PCR assays for PaV1, a test sample that did
not amplify had to contain ≥ 1.5 ng of DNA in Round 1
(125-fold the genomic DNA end point) to be considered negative for the virus.
We also tested the specificity of the PCR assay for
PaV1 against 2 known herpes viruses (Fig. 3). Neither

Fig. 2. Titration of genomic DNA from infected hemolymph
shows that the PCR assay for PaV1 was highly sensitive. Lanes:
1, 100 bp ladder; 2, ddH2O control; 3, p892 positive control; 4 to
10, genomic DNA from infected hemolymph starting at 12 ng
and serially diluted 10-fold. C: 500 bp marker

the tissues infected with OsHV1 (Fig. 3A, Lanes 6
and 7), nor those infected with murine cytomegalovirus
(Fig. 3C, Lane 4) produced amplicons in a Round 1
PCR assay for PaV1. Furthermore, PaV1 primers did
not react with host oyster DNA (Fig. 3A, Lanes 4
and 5). Two specific PCR assays confirmed infection in
these tissues; an OsHV1 PCR generated the expected
352 bp product from OsHV1 (Fig. 3B, Lanes 3 and 4)
and the PCR assay for herpes virus DNA polymerase
gave the expected band at ~745 bp (Fig. 3D, Lane 1).
The PCR assay for PaV1 detected viral infection in
inoculated lobsters throughout the course of infection
(Fig. 4). All of the lobsters were collected in the wild
from Florida Bay populations and were thus subject to
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Fig. 4. Detection of virus in PaV1-inoculated lobsters. (A) The
PCR assay for PaV1 detected viral infection during the entire
incubation time from the onset of infection to the diseased
state in the laboratory setting. Lanes: 1 and 15, 100 bp ladders; 2, citrate anticoagulant; 3 and 14, plasmid p892 positive
control; 4 to 8, pre-inoculation DNA from 5 lobsters; 9 to 13,
post-inoculation DNA from each of the 5 lobsters collected on
Days 10, 21, 45, 55, and 65 post-inoculation, respectively.
(B) Plasmid spike test of the extracts used in Panel A shows
that PCR inhibitors were not present in the reaction mixtures.
Lanes: 2 to 14, the same extracts as for Panel A, except that
50 ng of plasmid p305 was added and the corresponding M13
primers were used in each reaction. C: 500 bp marker

Fig. 3. The PCR assay was specific for PaV1. (A) PaV1 PCR tested
against OsHV1-infected tissues. Lanes: 1, 100 bp ladder; 2, ddH2O
control; 3, plasmid p892 positive control; 4 and 5, DNA from uninfected oysters (1 µg); 6 and 7, DNA from infected oysters (1 µg).
(B) OsHV1 PCR tested against OsHV1-infected tissues. Lanes: 1
and 2, DNA from uninfected oysters (1 µg); 3 and 4, DNA from
OsHV1-infected tissues (1 µg); 5, 100 bp ladder. (C) PaV1 PCR
tested against murine cytomegalovirus. Lanes: 1, 50 bp ladder;
2, H2O control; 3, plasmid p892 positive control; 4, DNA from murine
cytomegalovirus (20 ng). (D) Herpesvirus PCR tested against murine cytomgalovirus. Lanes: 1, DNA from murine cytomegalovirus
(20 ng); 2, 50 bp ladder. C b: 500 bp markers

potential viral exposure under natural conditions; however, the 5 lobsters selected at representative points in
the time course (Fig. 4A) showed no visible signs of
infection immediately prior to inoculation and tested
negative in the PCR assay for PaV1. A 499 bp band in
the PCR assay for PaV1 indicates the presence of PaV1
at 10 d post-inoculation through 65 d post-inoculation

(Lanes 9 to 13). Hemolymph was not acquired for PaV1
testing prior to Day 10, so detection may be possible
even sooner after inoculation. The negative results for
all of the pre-inoculation animals shown after two
30 cycle rounds of PCR further demonstrate that the
PaV1 primers do not amplify host lobster DNA (Lanes
4 to 8).
Overall, the PCR assay detected infection in ~78% of
inoculated lobsters (Table 2A,C), but assay detection
rises to 94% if one includes the 3 lobsters that appeared to clear PaV1 from their hemolymph (Table 2B).
The sample classified as ‘inconclusive’ (Table 2E) was
Table 2. PCR detection of PaV1 in 18 lobsters inoculated with
infected hemolymph
Pre- and post-inoculation result

Lobsters (N)

Percent

A. Negative → Positive
B. Negative → Negative
C. Positive → Positive
D. Positive → Negative
E. Inconclusive

13
3
1
0
1

72.2
16.7
5.5
0.0
5.5

TOTAL

18

100.0

Montgomery-Fullerton et al.: PCR assay for lobster PaV1

unusual in that the 499 bp band produced in Round 1
failed to amplify in Round 2; this represents the single
such incidence observed thus far. It is technically difficult to evaluate the PCR assay for PaV1 in terms of
false-negative and false-positive readings, as there are
no methods that can absolutely confirm the absence of
virus in wild-caught lobsters and confirming infection
by electron microscopy would require substantial effort
to detect low level infections. However, all healthy
hemolymph samples spiked with virus tested PCR positive, and repeated tests of PCR-negative samples were
consistently negative.
The genomic DNA extraction procedure removed
PCR inhibitors from the sample (Fig. 4B). The 481 bp
band from the spiked plasmid p305 shows that Taq
polymerase, in the presence of hemolymph extracts,
was fully functional and could generate amplicons
from the plasmid. The results of the spike test also
indicate that the PCR assay for PaV1 is not readily
susceptible to false-negative readings originating from
sample processing.
Because purified virus and laboratory-maintained
inoculated lobsters were used to set up the PaV1
screening assay, it was necessary to test hemolymph
samples from both healthy and diseased lobsters
from the Florida Keys where natural infections are
prevalent (Fig. 5). Twelve field-collected samples were
selected because they showed a distribution of band
intensities from a typical PCR screening effort; negative in Rounds 1 and 2 (Lanes 4 to 7), low-intensity

Fig. 5. The PCR assay for PaV1 detects the presence of PaV1
in naturally exposed lobsters. Lanes: 1 and 17, 100 bp ladders;
2, citrate anticoagulant; 3 and 16, plasmid p892 positive control; 4 to 15, twelve lobsters collected from the Florida Keys.
C: 500 bp marker
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499 bp bands in Round 1 that were amplified in
Round 2 (Lanes 8 to 11), and strong bands in both
rounds (Lanes 12 to 15). The lobsters shown in Fig. 4
were collected at different times and from different
locations in 2003. Considering that lobsters from 2004
had similar patterns (not shown), the results indicate
that the PCR assay for PaV1 detects a stable viral
marker and thus can be used to screen wild-caught or
laboratory lobsters for infection.

DISCUSSION
We have developed the first PCR-based assay for the
detection of a lobster-specific virus. The PaV1 primers
were selected from an 892 bp sequence that was cloned
from purified virus in a related PaV1 project (R. E. Ratzlaff unpubl. data). The PCR assay can be used to screen
live lobsters Panulirus argus, both inoculated and naturally infected, using a relatively small volume of hemolymph (20 µl); it thereby poses negligible risk to the
lobster. The virus was detectable within 10 d of inoculation (at a minimum) and throughout the course of infection in hosts inoculated in a laboratory setting. Purified
DNA from PaV1 was detectable from as low as 1.2 fg,
though the number of virions this represents cannot be
calculated until the size of the PaV1 genome has been
determined. For a general comparison, a koi herpesvirus PCR with a sensitivity of 10 fg was estimated to
detect 30 virions (Bercovier et al. 2005).
Based on the testing of hemolymph samples, the PCR
assay for PaV1 conclusively detected infection in 78%
of inoculated lobsters; furthermore, the detection of
virus would be 94% if host resistance to PaV1 was
clearly established. The assay was developed for the
testing of unclotted hemolymph samples, but, in preliminary experiments, the PCR assay detected PaV1 in
extracts of clotted hemolymph and the hepatopancreas
(data not shown). To the extent that we were able to
evaluate specificity, the PCR assay for PaV1 did not
react with lobster DNA, oyster DNA, OsHV1, or murine
cytomegalovirus. Direct tests of other viruses have not
been done; however, a BLAST search found that there
was no significant similarity between the sequences
of our PaV1 primers when compared with the genomic
sequences of several putatively related viruses: OsHV1
(Herpesviridae), Frog Virus 3 (Iridoviridae), Singapore Grouper Iridovirus, Lymphocystis Disease Virus 1
(Iridoviridae), or Shrimp White Spot Syndrome Virus
(Nimaviridae).
With regard to the handling of hemolymph samples,
there are at least 3 sources of inhibition that necessitate stringent quality control measures to ensure the
removal of inhibitors during the preparatory steps.
Lobster hemolymph without anticoagulants and the
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anticoagulants themselves can inhibit the PCR reaction.
We used 2 anticoagulants successfully in the present
study: sodium citrate/EDTA (Söderhäll & Smith 1983)
and lobster salt solution with EDTA (Hernández-López
et al. 2003). Both inhibit PCR, likely due to their EDTA
content, but both anticoagulants can be removed from
the sample DNA in the extraction process. Genomic
DNA sample volumes >10 µl showed significant inhibition in the p305 plasmid spike test, possibly due to
trace amounts of denaturing agents from the DNA
extraction kit. However, with quality-control measures
in place, the PCR assay for PaV1 was a reliable and
sensitive test for the detection of viral infection in lobsters.
The PCR assay was developed to screen lobsters for
PaV1, and we have attempted to address the key step
in this process, that is, the criteria used to determine
the infection status. Ultimately, infection must be
determined objectively by viewing PCR bands of
varying intensities. A 2-round, low-cycle-number PCR
assay was useful for discriminating very weak-intensity
band artifacts in the small percentage of samples that
posed a problem for interpretation. We observed 3
such instances in the >100 samples tested, and the
bands were always of very low intensity and all failed
to amplify in Round 2. Thus, the standard for assignment of PCR-negative status is either the absence of
499 bp bands in Round 1 or the failure of weak bands
to amplify in Round 2. We observed only 1 inconclusive
sample, which showed a strong 499 bp band in
Round 1, but, for unknown reasons, failed to amplify in
Round 2. PCR-positive lobsters were assigned to 1 of
2 general categories: those with low-intensity 499 bp
bands in Round 1 that were amplified in Round 2 and
those with strong bands in both rounds. The intensity
of the bands was not easily attributed to the total
amount of DNA in the hemolymph extract, although
non-infected lobsters tended to yield less DNA. From a
larger set of comparable samples (N = 73), the DNA
levels in the PCR assay were 16 ± 9, 31 ± 30, and 24 ±
18 ng (SD) for negative, low-intensity, and strong
499 bp bands, respectively. In spite of this variability,
it is possible that hemolymph DNA levels rise with the
spread of the virus within the host and drop as hemocytes are destroyed. Therefore, our preliminary conclusion, in the absence of more quantitative data, is
that the intensity of the 499 bp PCR band reflects the
viral load in infected lobsters.
This study represents the second molecular detection assay developed for PaV1. A highly sensitive and
specific FISH assay (Li et al. 2007), that can be used
to assess the tropic nature of PaV1 in host tissues,
should prove useful in characterizing the development
of the disease process in lobsters. The advantage of a
PCR assay for PaV1 lies in its ability to detect infections

that may not be associated with pathology. Additionally, it allows for non-destructive assessment and
monitoring of the prevalence and progression of infection in the fishery, as demonstrated by the laboratory
trial and analysis of field isolates. The future application of both molecular techniques should help us understand the underlying nature of the disease caused by
PaV1.
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